HOw Patients view Extended half-life products: Impressions from real-world experience (The HOPE study)

Haemophilia : the Official Journal of the World Federation of Hemophilia
Kate KhairMichael Holland

Abstract

Extended half-life (EHL) clotting factors have been shown to offer people with haemophilia (PwH) protection from bleeding with fewer infusions, which might reduce treatment burden. The HOw Patients view Extended half-life products (HOPE) study aimed to explore, understand and describe patient expectations around the prophylactic use of EHL products and to establish whether these expectations were met through individual follow-up analysis. The HOPE study was a prospective, qualitative cohort study conducted among PwH who had switched to Fc fusion protein EHL products in routine clinical care and who had not been recruited to clinical trials of these products. Semi-structured audio-recorded interviews were undertaken over two time points; transcripts were analysed to systematically generate theory from data that contains both inductive and deductive thinking. Forty-three interviews were conducted with 25 participants. Most participants were positive about EHL treatment and intended to continue using them. Reduced frequency of infusions meant lives were less disrupted or dominated by haemophilia, and there was less perceived stress on overused veins. For those PwH who did not reduce infusion frequency, there were other perceived b...Continue Reading

References

Oct 23, 2002·International Journal for Quality in Health Care : Journal of the International Society for Quality in Health Care·Crispin JenkinsonStephen Bruster
Nov 15, 2013·Blood·Johnny MahlanguUNKNOWN A-LONG Investigators
Dec 7, 2013·The New England Journal of Medicine·Jerry S PowellUNKNOWN B-LONG Investigators
Aug 11, 2015·Journal of Advanced Nursing·Kim WardKaren Hoare
Dec 5, 2015·Patient Preference and Adherence·Shraddha S ChauguleGuy Young
Jan 13, 2016·Blood·Elena SantagostinoUNKNOWN PROLONG-9FP Investigators Study Group
Jun 18, 2016·Haemophilia : the Official Journal of the World Federation of Hemophilia·P CollinsA Thomas
Mar 30, 2017·Journal of Clinical Medicine·Maria Elisa Mancuso, Elena Santagostino
Apr 4, 2017·Haemophilia : the Official Journal of the World Federation of Hemophilia·S von MackensenJ Oldenburg
Feb 3, 2018·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·Carolyn E SchwartzAdi Eldar-Lissai

❮ Previous
Next ❯

Citations

Sep 17, 2020·Haemophilia : the Official Journal of the World Federation of Hemophilia·Jun SuRonald Preblick
Jul 16, 2021·Haemophilia : the Official Journal of the World Federation of Hemophilia·Simon FletcherKate Khair
Sep 22, 2021·Haemophilia : the Official Journal of the World Federation of Hemophilia·Maria Elisa MancusoKarin Fijnvandraat

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.